Our novel model met the requirements for AD induction, and this was confirmed by significant memory decline, elevation in brain lipid peroxidation biomarkers, Aβ1-42 deposits, p-tau (Ser202) positive cells, TNF-α and IL-1β, as well as caspase-3 and AChE activity. The gene discussed is CASP3; the disease is Alzheimer disease.